We previously demonstrated that AGP upregulates RASSF1A in three metastatic colon cancer cell lines, in AGP treated mice bearing human colon cancer tissue cells, and in a patient-derived 3D colon cancer organoid model (PD3D) [25]. Here, ATP5MK is linked to colonic neoplasm.